标题
MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
作者
关键词
Ovarian cancer, CA125, MUC16, Cancer biomarker, Metastasis, Immunesupression, Natural killer cells
出版物
Molecular Cancer
Volume 13, Issue 1, Pages 129
出版商
Springer Nature
发表日期
2014-05-29
DOI
10.1186/1476-4598-13-129
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Results From Four Rounds of Ovarian Cancer Screening in a Randomized Trial
- (2014) Edward Partridge et al. OBSTETRICS AND GYNECOLOGY
- The Role of Mesothelin in Tumor Progression and Targeted Therapy
- (2013) Zhewei Tang et al. Anti-Cancer Agents in Medicinal Chemistry
- Assessment of Sialic Acid Diversity in Cancer- and Non-Cancer Related CA125 Antigen Using Sialic Acid-Binding Ig-Like Lectins (Siglecs)
- (2013) N. Mitic et al. DISEASE MARKERS
- OC125, M11 and OV197 Epitopes Are Not Uniformly Distributed in the Tandem-Repeat Region of CA125 and Require the Entire SEA Domain
- (2013) Alessandro Bressan et al. DISEASE MARKERS
- CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell–cell adhesion
- (2013) Kaoru Akita et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- Exploring the Glycosylation of Serum CA125
- (2013) Radka Saldova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study
- (2013) Paul Sabbatini et al. JOURNAL OF CLINICAL ONCOLOGY
- Microarray Glycoprofiling of CA125 Improves Differential Diagnosis of Ovarian Cancer
- (2013) Kowa Chen et al. JOURNAL OF PROTEOME RESEARCH
- Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing
- (2013) Caroline B. Madsen et al. PLoS One
- MicroRNA-200c Modulates the Expression of MUC4 and MUC16 by Directly Targeting Their Coding Sequences in Human Pancreatic Cancer
- (2013) Prakash Radhakrishnan et al. PLoS One
- Coexpression of MUC16 and mesothelin is related to the invasion process in pancreatic ductal adenocarcinoma
- (2012) Atsushi Shimizu et al. CANCER SCIENCE
- Reflection on the Discovery of Carcinoembryonic Antigen, Prostate-Specific Antigen, and Cancer Antigens CA125 and CA19-9
- (2012) E. P. Diamandis et al. CLINICAL CHEMISTRY
- Potential effect of the risk of ovarian cancer algorithm (ROCA) on the mortality outcome of the Prostate, Lung, Colorectal and Ovarian (PLCO) trial
- (2012) Paul F. Pinsky et al. INTERNATIONAL JOURNAL OF CANCER
- Different Levels of Sialyl-Tn Antigen Expressed on MUC16 in Patients With Endometriosis and Ovarian Cancer
- (2012) Kaoru Akita et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Pathobiological Implications of MUC16/CA125 Expression in Intrahepatic Cholangiocarcinoma-Mass Forming Type
- (2012) Michiyo Higashi et al. PATHOBIOLOGY
- A Metalloproteinase Secreted by Streptococcus pneumoniae Removes Membrane Mucin MUC16 from the Epithelial Glycocalyx Barrier
- (2012) Bharathi Govindarajan et al. PLoS One
- Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells
- (2011) M Comamala et al. BRITISH JOURNAL OF CANCER
- MUC1 and MUC4: Switching the Emphasis from Large to Small
- (2011) Huguette Albrecht et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- The Sine Qua Non of Discovering Novel Biomarkers for Early Detection of Ovarian Cancer: Carefully Selected Preclinical Samples
- (2011) I. Jacobs et al. Cancer Prevention Research
- A Framework for Evaluating Biomarkers for Early Detection: Validation of Biomarker Panels for Ovarian Cancer
- (2011) C. S. Zhu et al. Cancer Prevention Research
- Ovarian Cancer Biomarker Performance in Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Specimens
- (2011) D. W. Cramer et al. Cancer Prevention Research
- Abagovomab for ovarian cancer
- (2011) Jacobus Pfisterer et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Mucin 16 is a functional selectin ligand on pancreatic cancer cells
- (2011) Shih-Hsun Chen et al. FASEB JOURNAL
- Correlation between CA-125 serum level and response by RECIST in a phase III recurrent ovarian cancer study
- (2011) Thomas J. Herzog et al. GYNECOLOGIC ONCOLOGY
- More than a biomarker: CA125 may contribute to ovarian cancer pathogenesis
- (2011) Robert C. Bast et al. GYNECOLOGIC ONCOLOGY
- MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis
- (2011) Catherine Thériault et al. GYNECOLOGIC ONCOLOGY
- Abagovomab: an anti-idiotypic CA-125 targeted immunotherapeutic agent for ovarian cancer
- (2011) Rachel N Grisham et al. Immunotherapy
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Evaluation of the Diagnostic Accuracy of the Risk of Ovarian Malignancy Algorithm in Women With a Pelvic Mass
- (2011) Richard G. Moore et al. OBSTETRICS AND GYNECOLOGY
- MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells
- (2011) I Lakshmanan et al. ONCOGENE
- Identification of pregnancy-associated CA125-reactive protein as a carbohydrate-binding immunoglobulin G
- (2010) Bojana Milutinović et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- The prognostic and predictive value of CA-125 regression during neoadjuvant chemotherapy for advanced ovarian or primary peritoneal carcinoma
- (2010) Naveen S. Vasudev et al. ARCHIVES OF GYNECOLOGY AND OBSTETRICS
- Muc1 oncoprotein suppresses activation of the ARF-MDM2-p53 pathway
- (2010) Deepak Raina et al. CANCER BIOLOGY & THERAPY
- Phase I Clinical Trial of the Chimeric Anti-Mesothelin Monoclonal Antibody MORAb-009 in Patients with Mesothelin-Expressing Cancers
- (2010) R. Hassan et al. CLINICAL CANCER RESEARCH
- How to follow-up patients with epithelial ovarian cancer
- (2010) Rowan E Miller et al. CURRENT OPINION IN ONCOLOGY
- Membrane-tethered mucins have multiple functions on the ocular surface
- (2010) Bharathi Govindarajan et al. EXPERIMENTAL EYE RESEARCH
- MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
- (2010) Jennifer AA Gubbels et al. Molecular Cancer
- Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytes
- (2010) Jennifer A. Belisle et al. Molecular Cancer
- Synthesis and structural characterization of the peptide epitope of the ovarian cancer biomarker CA125 (MUC16)
- (2010) Zach T. Berman et al. TUMOR BIOLOGY
- CA125 (MUC16) tumor antigen selectively modulates the sensitivity of ovarian cancer cells to genotoxic drug-induced apoptosis
- (2009) Marianne Boivin et al. GYNECOLOGIC ONCOLOGY
- Association of Cell Surface Mucins with Galectin-3 Contributes to the Ocular Surface Epithelial Barrier
- (2009) Pablo Argüeso et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
- (2009) Usha Menon et al. LANCET ONCOLOGY
- Inhibition of mesothelin–CA-125 interaction in patients with mesothelioma by the anti-mesothelin monoclonal antibody MORAb-009: Implications for cancer therapy
- (2009) Raffit Hassan et al. LUNG CANCER
- CA125/MUC16 Is Dispensable for Mouse Development and Reproduction
- (2009) Dong-Joo Cheon et al. PLoS One
- Mucin-interacting proteins: from function to therapeutics
- (2009) Shantibhusan Senapati et al. TRENDS IN BIOCHEMICAL SCIENCES
- Expression and Epitope Characterization of a Recombinant CA 125 Repeat: Fourth Report from the ISOBM TD-1 Workshop
- (2009) David J. Warren et al. TUMOR BIOLOGY
- Mesothelin, Stereocilin, and Otoancorin are predicted to have superhelical structures with ARM-type repeats
- (2009) Bangalore K Sathyanarayana et al. BMC STRUCTURAL BIOLOGY
- National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
- (2008) C. M. Sturgeon et al. CLINICAL CHEMISTRY
- MUC16 expression during embryogenesis, in adult tissues, and ovarian cancer in the mouse
- (2008) Ying Wang et al. DIFFERENTIATION
- A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass
- (2008) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
- A Binding Domain on Mesothelin for CA125/MUC16
- (2008) Osamu Kaneko et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin
- (2008) Hilary A. Kenny et al. JOURNAL OF CLINICAL INVESTIGATION
- Mesothelin targeted cancer immunotherapy
- (2007) Raffit Hassan et al. EUROPEAN JOURNAL OF CANCER
- The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass
- (2007) Richard G. Moore et al. GYNECOLOGIC ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search